Moreover, ADCs polarize tumour-associated macrophages (TAMs) towards pro-inflammatory M1 phenotypes by upregulating toll-like receptor 4 (TLR4) and suppressing scavenger receptor class A member 5 (SCARA5), thereby enhancing phagocytosis and IL-12 secretion (38). Here, SCARA5 is linked to neoplasm.